SPECT imaging and biodistribution studies of 111In-EGF-Au-PEG nanoparticles in vivo

SPECT imaging and biodistribution studies of 111In-EGF-Au-PEG nanoparticles in vivo

Radiolabelled antibodies and peptides hold promise for molecular radiotherapy but are often limited by low payload resulting in delivery of inadequate amounts of radioactivity to tumour tissue and, therefore, modest therapeutic effect. We have developed PEGylated epidermal growth factor (EGF)-gold n...

書誌詳細
主要な著者:	Song, L, Able, S, Falzone, N, Kersemans, V, Vallis, K
フォーマット:	Conference item
出版事項:	SpringerOpen 2016

類似資料

Accumulation of 111In-Labelled EGF-Au-PEG Nanoparticles in EGFR-Positive Tumours is Enhanced by Co-administration of Targeting Ligand
著者:: Song, L, 等
出版事項: (2017)

Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors.
著者:: Cornelissen, B, 等
出版事項: (2013)

EGF-coated gold nanoparticles provide an efficient nano-scale delivery system for the molecular radiotherapy of EGFR-positive cancer.
著者:: Song, L, 等
出版事項: (2016)

A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
著者:: Reilly, R, 等
出版事項: (2000)

Imaging DNA damage response (DDR) during oncogenesis
著者:: Cornelissen, B, 等
出版事項: (2013)

111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR.
著者:: Reilly, R, 等
出版事項: (2000)

In-111-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR
著者:: Reilly, R, 等
出版事項: (2000)

Biodistribution of 68/67Ga-Radiolabeled Sphingolipid Nanoemulsions by PET and SPECT Imaging
著者:: Díez-Villares S, 等
出版事項: (2021-08-01)

Biodistribution of gold nanoparticles <i>in vivo</i>
著者:: Yu. A. Finogenova, 等
出版事項: (2025-01-01)

Quantitative Biodistribution of OMVs Using SPECT/CT Imaging with HYNIC-Duramycin Radiolabeling
著者:: Dávid Szöllősi, 等
出版事項: (2024-10-01)

Biodistribution of Multimodal Gold Nanoclusters Designed for Photoluminescence-SPECT/CT Imaging and Diagnostic
著者:: Greta Jarockyte, 等
出版事項: (2022-09-01)

Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using (111)In-bevacizumab.
著者:: Patel, N, 等
出版事項: (2017)

Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile
著者:: Rafiei P, 等
出版事項: (2017-01-01)

Novel Biocompatible Au Nanostars@PEG Nanoparticles for In Vivo CT Imaging and Renal Clearance Properties
著者:: Daiyuan Tang, 等
出版事項: (2017-10-01)

A Correlative Imaging Study of in vivo and ex vivo Biodistribution of Solid Lipid Nanoparticles
著者:: Mannucci S, 等
出版事項: (2020-03-01)

ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.
著者:: Cornelissen, B, 等
出版事項: (2011)

Effects of PEG surface density and chain length on the pharmacokinetics and biodistribution of methotrexate-loaded chitosan nanoparticles
著者:: Ait Bachir Z, 等
出版事項: (2018-09-01)

Biodistribution and imaging of an hsp90 ligand labelled with 111In and 67Ga for imaging of cell death
著者:: Ivan Ho Shon, 等
出版事項: (2020-01-01)

Biodistribution and nuclear import of 111In-labeled HIV-1 tat peptide immunoconjugates after intravenous or intratumoural injection in tumour-bearing mice
著者:: Cornelissen, B, 等
出版事項: (2006)

Pharmacokinetics, Biodistribution, and Biosafety of PEGylated Gold Nanoparticles In Vivo
著者:: Katarina Kozics, 等
出版事項: (2021-06-01)

Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using 111In-bevacizumab
著者:: Neel Patel, 等
出版事項: (2017-05-01)

I131-MIBG treatment revisited: How important is scheduling when combined with external beam irradiation?
著者:: Corroyer-Dulmont, A, 等
出版事項: (2016)

Relationship between induction of phosphorylated H2AX and survival in breast cancer cells exposed to 111In-DTPA-hEGF.
著者:: Cai, Z, 等
出版事項: (2008)

Computational analysis of the number, area and density of gamma-H2AX foci in breast cancer cells exposed to (111)In-DTPA-hEGF or gamma-rays using Image-J software.
著者:: Cai, Z, 等
出版事項: (2009)

Comparative antiproliferative effects of (111)In-DTPA-hEGF, chemotherapeutic agents and gamma-radiation on EGFR-positive breast cancer cells.
著者:: Chen, P, 等
出版事項: (2002)

In vivo gadolinium nanoparticle quantification with SPECT/CT
著者:: Olga Kochebina, 等
出版事項: (2019-06-01)

Auger electron therapy using In-111-labelled F3 peptide
著者:: Cornelissen, B, 等
出版事項: (2011)

Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [111In]DTPA-hEGF.
著者:: Hu, M, 等
出版事項: (2007)

Preparation and Complex Characterisation of Stabilised Gold Nanoparticles: Biodistribution and Application for High Resolution In Vivo Imaging
著者:: Jaroslav Turánek, 等
出版事項: (2024-11-01)

Indium-111 radiolabelling of a brain-penetrant Aβ antibody for SPECT imaging
著者:: Tobias Gustavsson, 等
出版事項: (2024-05-01)

Assessment of four scatter correction methods in In-111 SPECT imaging: A simulation study
著者:: Mahsa Noori-Asl
出版事項: (2020-01-01)

PEG Conjugated Zein Nanoparticles for In Vivo Use
著者:: Courtney van Ballegooie, 等
出版事項: (2022-08-01)

Use of the Highly Biocompatible Au Nanocages@PEG Nanoparticles as a New Contrast Agent for In Vivo Computed Tomography Scan Imaging
著者:: Yan Gao, 等
出版事項: (2020-03-01)

Controlling in Vivo Stability and Biodistribution in Electrostatically Assembled Nanoparticles for Systemic Delivery
著者:: Poon, Zhiyong, 等
出版事項: (2013)

In vivo Biodistribution and Clearance of Magnetic Iron Oxide Nanoparticles for Medical Applications
著者:: Nowak-Jary J, 等
出版事項: (2023-07-01)

In vivo evaluation of safety, biodistribution and pharmacokinetics of laser-synthesized gold nanoparticles
著者:: Anne-Laure Bailly, 等
出版事項: (2019-09-01)

The Bioavailability, Biodistribution, and Toxic Effects of Silica-Coated Upconversion Nanoparticles in vivo
著者:: Mingzhu Zhou, 等
出版事項: (2019-04-01)

Correlation between radioactivity and chemotherapeutics of the 111In-VNB-liposome in pharmacokinetics and biodistribution in rats
著者:: Tsai TH, 等
出版事項: (2012-02-01)

111In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells
著者:: Gill, M, 等
出版事項: (2018)

111In-BnDTPA-F3: an Auger electron-emitting radiotherapeutic agent that targets nucleolin.
著者:: Cornelissen, B, 等
出版事項: (2012)